Shaping the future of education in health care and medical sciences
Breaking Through Autism
The Center for Disease Control and Prevention has found that 1 in 88 people are affected by autism spectrum disorders (ASD), a disorder four times more common in boys than in girls. At the Seaver Autism Center for Research and Treatment, we are dedicated to...
Is Marijuana Harmless?
Marijuana (Cannabis sativa) is the illicit drug most commonly used by teenagers in the United States. Although cannabis is not as addictive as other substances, such as heroin and cocaine, cannabis-dependent individuals still greatly outnumber those reporting...
Rapid Treatment for the Depressed Brain
Is it possible to rapidly elevate the depressed mood? This has been a pressing question over the past 50 years because classic antidepressants, such as Prozac, are known to take weeks to reach clinical efficacy; combining medications to enhance antidepressant outcomes...
Treating Depression More Rapidly & Effectively
The prevalence rate for depression in the United States is nearly 7%, yet standard antidepressants produce full remission in only 30-40% of patients. Even when treatment is effective, patients require 2-4 weeks to achieve the full therapeutic effects. Adding to the...
Day 3 of IFMSA: Interview with Mariko Kondo
Today was the last day of the IFMSA conference, and Dean for Medical Education, Dr. David Muller addressed the students who braved the snow this morning, followed by a panel with Dr. Muller, Katie Robbins (PNHP, Healthcare NOW!), and Icahn School of Medicine at Mount...
Day 2: IFMSA Delegate Profile
Jesper Moelgaard, 31, is a 5th year medical student at the University of Copenhagen, Denmark. He was originally interested in Anesthesiology and is now focusing on Societal Medicine Since this is his first time ever in America, I sat down with Jesper to chat about his...